CX Institutional Takes Position in GSK PLC Sponsored ADR (NYSE:GSK)
CX Institutional purchased a new stake in GSK PLC Sponsored ADR (NYSE:GSK – Free Report) in the first quarter, HoldingsChannel reports. The fund purchased 1,175 shares of the pharmaceutical company’s stock, valued at approximately $46,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes in GSK. Integrated Advisors Network […]
CX Institutional purchased a new stake in GSK PLC Sponsored ADR (NYSE:GSK – Free Report) in the first quarter, HoldingsChannel reports. The fund purchased 1,175 shares of the pharmaceutical company’s stock, valued at approximately $46,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes in GSK. Integrated Advisors Network […]
